Revolution Medicines, Inc.RVMD
NasdaqGS•Healthcare•Biotechnology
Understand cash generation quality and how management allocates capital.
Free cash flow was $-355.70M in the latest quarter (79.9% decrease YoY). Shares outstanding increased by 5.3% year-over-year, indicating dilution (potentially from stock compensation or capital raises). Free cash flow is the lifeblood of a business — it funds dividends, buybacks, debt reduction, and reinvestment without relying on external capital.
Free cash flow, earnings quality, and capital allocation